In this hospital-based case-control study, we found that the TNFAIP2 miR-184 binding site variant rs8126 CC genotype was significantly associated with an elevated risk of developing gastric cancer in a recessive genetic model. The gene discussed is TNFAIP2; the disease is gastric cancer.